NCT06786988Not yet recruiting
Cerebral Safety After Pulsed-Field Ablation of Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 22 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A study evaluating the incidence of ischaemic lesions detected by brain MRI scan in subjects undergoing pulsed-field ablation for atrial fibrillation (VARIPULSE system).
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 40 (estimated)
- First submitted
- 10 Jan 2025
- Start date
- 1 Feb 2025
- Primary completion date
- 1 Dec 2025
- Lead sponsor
- Charles University, Czech Republic
- Diseases
- Atrial fibrillation
- NCT number
- NCT06786988
What you commit to
- Study type: Observational
- Planned participants: 40
- From 1 Feb 2025 to the primary completion date, 1 Dec 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- MRI contraindication
Who the study is looking for
- AF with an indication for ablation
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Related publications
- Cerebrovascular Ischemic Lesions After Pulsed Field Ablation for Atrial Fibrillation Using Variable-Loop Ablation Catheter.JACC Clin Electrophysiol · 2026 · PMID 41575412
This page is information, not medical advice. Discuss any trial with your doctor.